John A. Lawson

23.3k total citations · 4 hit papers
250 papers, 15.4k citations indexed

About

John A. Lawson is a scholar working on Pharmacology, Psychiatry and Mental health and Biochemistry. According to data from OpenAlex, John A. Lawson has authored 250 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pharmacology, 48 papers in Psychiatry and Mental health and 44 papers in Biochemistry. Recurrent topics in John A. Lawson's work include Inflammatory mediators and NSAID effects (50 papers), Epilepsy research and treatment (43 papers) and Eicosanoids and Hypertension Pharmacology (42 papers). John A. Lawson is often cited by papers focused on Inflammatory mediators and NSAID effects (50 papers), Epilepsy research and treatment (43 papers) and Eicosanoids and Hypertension Pharmacology (42 papers). John A. Lawson collaborates with scholars based in United States, Australia and Italy. John A. Lawson's co-authors include Garret A. FitzGerald, Joshua Rokach, Domenico Praticò, Shiv Kapoor, Muredach P. Reilly, Issam A. Mardini, Brendan McAdam, Andrew Bleasel, Francesca Catella-Lawson and Norman Delanty and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

John A. Lawson

240 papers receiving 14.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2

1999 1.0k citations Francesca Catella-Lawson, Shiv Kapoor et al. profile →
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂

2002 667 citations Tilo Großer, John A. Lawson et al. profile →
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.

1983 540 citations Garret A. FitzGerald, John A. Lawson et al. Journal of Clinical Investigation profile →
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

2016 500 citations Jacqueline A. French, John A. Lawson et al. profile →

Peers

Countries citing papers authored by John A. Lawson

Since Specialization

Citations

This map shows the geographic impact of John A. Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Lawson more than expected).

Fields of papers citing papers by John A. Lawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Lawson. The network helps show where John A. Lawson may publish in the future.

Co-authorship network of co-authors of John A. Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Lawson. A scholar is included among the top collaborators of John A. Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Lawson. John A. Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep Sequencing and Phenotyping in an Australian Tuberous Sclerosis Complex “No Mutations Identified” Cohort 2024 ·Molecular Genetics & Genomic Medicine ·(unknown), Adam Bournazos, (unknown), Vanessa Sarkozy, John A. Lawson, Seán Kennedy, Sandra T. Cooper, Edwin P. Kirk, David Mowat	1
2	Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial 2022 ·Epilepsia ·(unknown), Carolyn Ellaway, Alexandra Johnson, (unknown), (unknown), Peter Galettis, Jennifer Martin, John A. Lawson	23
3	Adjunctive everolimus therapy for tuberous sclerosis complex‐associated refractory seizures: Results from the postextension phase of EXIST‐3 2021 ·Epilepsia ·David Neal Franz, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Dennis Dlugos, (unknown), Séverine Peyrard, Diana Pelov, Jacqueline A. French	23
4	Eye movement disorders are an early manifestation of CACNA1A mutations in children 2016 ·Esther Tantsis, Deepak Gill, Lyn R. Griffiths, Sachin Gupta, John A. Lawson, Neven Maksemous, Robert Ouvrier, Florence Riant, Robert L. Smith, Christopher Troedson, Richard Webster, Manoj P. Menezes	2
5	A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood 2016 ·JCI Insight ·Liudmila L. Mazaleuskaya, John A. Lawson, Xuanwen Li, Gregory R. Grant, Clementina Mesaros, Tilo Großer, Ian A. Blair, Emanuela Ricciotti, Garret A. FitzGerald	26
6	Ten-Year Single-Center Experience of the Ketogenic Diet: Factors Influencing Efficacy, Tolerability, and Compliance 2015 ·The Journal of Pediatrics ·(unknown), (unknown), (unknown), (unknown), Fiona Mackie, John A. Lawson, Michael Cardamone	59
7	Prostaglandin D ₂ Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia 2012 ·Science Translational Medicine ·Luis A. Garza, Yaping Liu, Zaixin Yang, Brinda Alagesan, John A. Lawson, Scott M. Norberg, Dorothy E. Loy, (unknown), Hanz Blatt, David C. Stanton, Lee Carrasco, Gurpreet S. Ahluwalia, Susan M. Fischer, Garret A. FitzGerald, George Cotsarelis	208
8	Drug Resistance and Pseudoresistance 2012 ·Circulation ·Tilo Großer, Susanne Fries, John A. Lawson, Shiv Kapoor, Gregory R. Grant, Garret A. FitzGerald	132
9	Aspirin reduces the prothrombotic activity of C-reactive protein 2009 ·Journal of Thrombosis and Haemostasis ·Etty Grad, Mordechai Golomb, Nickolay Koroukhov, John A. Lawson, Chaim Lotan, Garret A. FitzGerald, Haim Danenberg	15
10	Noninvasive Assessment of the Role of Cyclooxygenases in Cardiovascular Health: A Detailed HPLC/MS/MS Method 2007 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Wen‐Liang Song, John A. Lawson, Miao Wang, (unknown), Garret A. FitzGerald	53
11	Structure–function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells 2007 ·Atherosclerosis ·(unknown), Sissel Lund‐Katz, John A. Lawson, Michael C. Phillips, Daniel J. Rader	15
12	12/15-Lipoxygenase Is Increased in Alzheimer's Disease 2004 ·American Journal Of Pathology ·Domenico Praticò, Victoria Zhukareva, Yuemang Yao, Kunihiro Uryu, Colin Funk, John A. Lawson, John Q. Trojanowski, Virginia M.‐Y. Lee	195
13	Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ 2003 ·Journal of Clinical Investigation ·(unknown), Tomomi Ide, John A. Lawson, Peter McNamara, Muredach P. Reilly, Garret A. FitzGerald	273
14	Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ 2003 ·Journal of Clinical Investigation ·(unknown), Tomomi Ide, John A. Lawson, Peter McNamara, Muredach P. Reilly, Garret A. FitzGerald	268
15	Intelligence in childhood epilepsy syndromes 2003 ·Epilepsy Research ·Melinda Nolan, (unknown), Sunčica Lah, Mark Sabaz, John A. Lawson, Anne M. Cunningham, Andrew Bleasel, (unknown)	117
16	Probabilistic Record Linkage for Genealogical Research 2002 ·BYU studies quarterly ·John A. Lawson, David White, Brenda Price, (unknown)	1
17	Isoprostane Activation of the Nuclear Hormone Receptor Ppar 2002 ·Advances in experimental medicine and biology ·Peter McNamara, John A. Lawson, Joshua Rokach, Garret A. FitzGerald	14
18	A Randomized, Placebo-Controlled, Crossover Study of E5510 and Aspirin in Healthy Volunteers 1999 ·Journal of Cardiovascular Pharmacology ·Muredach P. Reilly, Niamh Moran, Emma A. Meagher, Norman Delanty, (unknown), John A. Lawson, Francesca Catella-Lawson	2
19	The Conversion of the Wesleys -- 1738 Reconsidered 1988 ·ePlace - Preserving, Learning, and Creative Exchange (Asbury Theological Seminary) ·John A. Lawson	0
20	Lectures concerning oratory 1972 ·Bayerische Staatsbibliothek ·John A. Lawson	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact